This scenario has been proposed and experimentally supported in the case of HER2/neu-expressing tumour cells in breast carcinomas (Peoples et al, 1995; Wiech et al, 2008, Goodell et al, 2008). This evidence concerns the gene ERBB2 and breast carcinoma.